Skip to main content
NKTR $36.32 -2.55%
NKTR logo
NKTR · Nektar Therapeutics
Track NKTR — free
$36.32 -0.95 (-2.55%) Play latest call Q3 2026 earnings call transcript
Market Cap
$1.28B
Shares
34.21M
Volume · Nov 16 216.39K Avg daily vol (3M) 1.1M
All webcasts

Earnings call · FY2022 Q1

Nektar Therapeutics (NKTR) Q1 2022 Earnings Call

Concluded May 5, 2022
May 5, 2022
Period
FY2022 Q1
Runtime
—
Sources
2 artifacts
Revenue $24.82M +5% YoY
Diluted EPS -$7.35
Gross margin · derived Q4 78.6% +2.9 pp YoY
Net income -$90.39M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Non Cash Royalty Revenue Related to Sale of Future Royalties$17.56M -6.6% YoY
Product$5.69M +18.6% YoY
License Collaboration and Other Revenue$1.57M +2813% YoY
Full-screen source Call document